Delivery Order SPE2DX15D1022-SPE2DX23FVPCE
- Not listed
- This federal contract award is for the delivery of Synthroid 25 mcg tablets to the Defense Logistics Agency (DLA) by AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract has a ceiling value of $1,538.52 and is a firm fixed-price delivery order without any set-aside designation, indicating open competition. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999 through November 2026, which serves...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of Synthroid (levothyroxine sodium) 50 mcg tablets. The $2,530.39 firm fixed-price delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, which provides a comprehensive range of pharmaceutical products and medical supplies to support military...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,080.12 firm fixed-price delivery order is for the supply of Synthroid 150 MCG Tablets in quantities of 1,000. The contract has an ultimate completion date of July 22, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical that serves as a...
- This federal contract award from the Defense Logistics Agency (DLA) was issued to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,958.96 firm fixed-price delivery order is for 4,567,034,802 units of Synthroid 88 MCG tablets, a medication used to treat hypothyroidism. The contract has an ultimate completion date of January 27, 2025. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This federal contract award, valued at $1,084.48, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order under the DLA's Indefinite Delivery Contract (IDC) valued at $999,999,999, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally....
- The Defense Logistics Agency (DLA) awarded a $6,472.26 Firm Fixed Price Delivery Order to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Synthroid 100 MCG Tablets. This order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 that AmerisourceBergen holds with the DLA Troop Support Medical, which serves as the primary vehicle for the company to deliver a comprehensive range of pharmaceutical products and medical supplies to...
- This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, covers the delivery of Synthroid 25 mcg tablets to the Defense Logistics Agency (DLA). The $2,152.14 firm-fixed-price delivery order has a completion date of January 17, 2023 and was awarded on January 13, 2023. There is no set-aside designation indicated for this contract. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp's Corporate Office Division. The $2,325.95 firm fixed price delivery order is for the supply of Synthroid 137 mcg tablets. Amerisourcebergen, a major pharmaceutical distributor, holds a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical valued at up to $999,999,999.00 through December 31, 2025. This single-award IDC serves as the primary...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The Delivery Order, valued at $7,120.16, is for the provision of Synthroid 88 MCG tablets. It is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen's parent company, Cencora, Inc., and the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through November 2026. This IDC...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,042.01, is a Firm Fixed Price Delivery Order for the supply of 4,567,422,798 units of the prescription drug Synthroid (88 mcg tablet). The contract has an ultimate completion date of March 3, 2025 and does not have a set-aside designation, indicating open competition. Amerisourcebergen holds a...
- SPE2DX15D1022Indefinite Delivery Contract
- SPE2DX15D1022-SPE2DX23FVPCEDelivery Order
This federal contract award was issued by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $34,288.57 firm fixed-price delivery order is for the supply of 4,562,098 units of the medication Synthroid 100 mcg tablets. The award is not associated with any set-aside program. Amerisourcebergen holds several large Indefinite Delivery Contracts (IDCs) with the DLA and other federal agencies to provide a wide range of pharmaceutical and medical products to support military treatment facilities, veterans' hospitals, and other government healthcare programs. These IDCs, valued up to $999,999,999 and $750,000 respectively, serve as primary vehicles for Amerisourcebergen to efficiently deliver critical care materials and prescription drugs to meet the medical needs of federal beneficiaries across the United States.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $34.3k | 9/8/23 |